Dr. Anthony Walker

Anthony Walker, Ph.D. is Partner at Alacrita.
 
Anthony leverages 12 years of building and managing a biotechnology company together with over 12 years as a management consultant to the chemical, pharma and biotechnology industries.
 
His experience includes due diligence, technology/market appraisal, business planning, licensing, raising venture capital finance, and M&A.
 
Prior to forming Alacrita, Anthony was CEO of Onyvax, a company he cofounded in 1997, raising over £35 million from blue chip life science investors including 3i and S.R. One.
 
Before Onyvax, he spent 10 years as a management consultant, specializing in the pharmaceutical and biotechnology industries. He consulted to Big Pharma and biotech, and also produced Expert Reports for five IPOs:

• At Arthur D. Little, he was appointed a European Director, responsible for the London-based pharmaceutical practice
• At The Wilkerson Group, he had responsibility for its UK consulting practice

Anthony authored Biotech in Israel — a Land of Promise, Viewpoint: Pharma Industry Myths, and Virtual is a Necessity, and coauthored A Way to Mitigate Outsourcing Risk? and An Alternative Future for the Pharmaceutical Industry.
 
Anthony earned his Honors degree in Natural Sciences and his Ph.D. in Biochemistry from the University of Cambridge.
 
Read his LinkedIn profile. Follow his Twitter feed.